Crescent Biopharma, Inc. (CBIO) earnings · rev $10.8M
These earnings events as JSON? API free 100/dayCrescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
This CBIO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CBIO revenue for 2025-12-31 was $10.8M. Net income was -$153.9M. CBIO currently screens at market cap $491.3M.
When the next CBIO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for CBIO. We will not invent a beat or miss.
Not investment advice. Full CBIO research stays on the stock page; the tape stays on the quote page.
CBIO earnings FAQ
What are CBIO's latest revenue and net income?
Latest cached Crescent Biopharma, Inc. (CBIO) revenue for Dec 31, 2025 was $10.8M. Net income was -$153.9M. Statements: https://lician.com/financials/cbio
What period does the latest CBIO earnings print cover?
The latest cached Crescent Biopharma, Inc. (CBIO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are CBIO earnings listed?
Cached earnings facts for Crescent Biopharma, Inc. (CBIO) are listed at https://lician.com/earnings/cbio. Statements: https://lician.com/financials/cbio
Not investment advice.